A new device that measures the level of oxygen in malignant tumors could improve the effectiveness of cancer treatments by making it easier for doctors to determine which treatments are working.
The “Oxylite” optic probe was developed by Britain’s Cancer Research Campaign (CRC). Based on the oxygen level in a given tumor, doctors can learn whether or not their treatment is effectively destroying the cancer. Dr. Trevor Hince, director of science at CRC, said “The probe will provide precise information to clinicians to improve treament.”
The new device will undergo clinic trials in the Netherlands and Britain later this year.